Software module finds patients with specific genetic markers in real time by using AI to contextualize genetic lab reports and unstructured genomics data in the EMR

软件模块通过使用AI将遗传实验室报告和EMR中的非结构化基因组学数据上下文化，实时发现具有特定遗传标记的患者

PASADENA, Calif., Sept. 6, 2023 /PRNewswire/ -- Deep 6 AI, the leading AI-powered clinical trial acceleration software, announces the launch of its genomics module to accelerate enrollment for precision medicine and oncology research. The software uses AI to mine genomics data across an entire electronic medical record (EMR) system and disparate genetic reports to find patients with specific genetic markers in real time.

帕萨迪纳，加利福尼亚州，2023年9月6日/PRNewswire/-Deep 6 AI，领先的AI驱动临床试验加速软件，宣布推出其基因组学模块，加速精准医学和肿瘤学研究的招生。该软件使用AI在整个电子病历（EMR）系统和不同的遗传报告中挖掘基因组数据，以实时找到具有特定遗传标记的患者。

Now, healthcare organizations and life sciences companies can precision-match patients to clinical trials based on their complete clinical and genomic profile, improving trial design, feasibility, and recruitment..

现在，医疗机构和生命科学公司可以根据患者完整的临床和基因组特征，精确地将患者与临床试验相匹配，从而改进试验设计，可行性和招募。。

Deep 6 AI's CEO, Wout Brusselaers, commented: 'Genetic markers have become increasingly important in determining a patient's eligibility for precision medicine and oncology clinical trials. But most of the salient genomics data is scattered across the EMR, requiring manual and time-consuming chart reviews that delay enrollment.

Deep 6 AI的首席执行官Wout Brusselaers评论说：“遗传标记在确定患者是否符合精准医学和肿瘤学临床试验的资格方面变得越来越重要。但是大多数显着的基因组学数据分散在整个EMR中，需要手动和耗时的图表审查，以延迟注册。

We found that out of 30 million patient health records from across the U.S., only approximately 100,000 records contained sequencing reports with extensive genomics data in a structured or semi-structured format, while approximately 500,000 records had rich genomics information buried in free-text clinician notes and reports.

我们发现，来自美国各地的3000万患者健康记录中，只有大约100000条记录包含具有结构化或半结构化格式的广泛基因组学数据的测序报告，而大约500000条记录具有隐藏在自由文本临床医生注释和报告中的丰富基因组学信息。

The beauty of the Deep 6 AI genomics module is that it uses natural language processing to contextualize all genomic and phenotypical clinical data—structured and unstructured—to precisely match patients to trials in minutes rather than months.'.

Deep 6 AI genomics模块的美丽之处在于它使用自然语言处理将所有结构化和非结构化的基因组和表型临床数据背景化，以便在几分钟而不是几个月内将患者精确匹配到试验中。

The genomics module is a natural expansion of the company's software platform. It leverages the expansive Deep 6 AI research ecosystem which consists of over 1,000 sites, including leading academic medical institutions and NCI-designated comprehensive cancer centers. Via a single, intuitive user interface, clinical researchers can query millions of patient records for over 19,000 genes, multiple mutation types (e.g., substitution, deletion, duplication, insertion, and indel) and over 30,000 locus-specific mutation names to find patients with specific genetic markers with unprecedented precision.

基因组学模块是公司软件平台的自然扩展。它利用了广泛的Deep 6 AI研究生态系统，该生态系统由1000多个站点组成，包括领先的学术医疗机构和NCI指定的综合癌症中心。通过单一，直观的用户界面，临床研究人员可以查询数百万患者记录中超过19000个基因，多种突变类型（例如，替换，缺失，重复，插入和插入缺失）和超过30000个基因座特异性突变名称，以前所未有的精确度找到具有特定遗传标记的患者。

In the software, IRB-approved researchers can identify each patient matched for a trial and quickly validate their eligibility. Additionally, the software finds patients that have specific genetic markers but are not eligible for a clinical trial today to enable researchers to prospectively monitor the disease, treatment response, and adverse reactions..

在该软件中，IRB批准的研究人员可以识别每个匹配进行试验的患者并快速验证其资格。此外，该软件还发现具有特定遗传标记但今天没有资格进行临床试验的患者，使研究人员能够前瞻性地监测疾病，治疗反应和不良反应。。

'Precision medicine and oncology trials require precise patient matching—and that's at the heart of what we do,' said Deep 6 AI's CEO, Wout Brusselaers. 'Since 2016, we've been using AI to mine structured and unstructured clinical data in the EMR, including physician notes, lab reports, outpatient notes, radiology reports, and pathology reports, to precision-match patients to the ideal clinical trials. Applying our AI to genomics data will accelerate and de-risk research and bring life-changing therapies to patients faster.'.

“精准医学和肿瘤学试验需要精确的患者匹配，这是我们所做的核心，”Deep 6 AI的首席执行官Wout Brusselaers说自2016年以来，我们一直在使用人工智能挖掘EMR中的结构化和非结构化临床数据，包括医生记录，实验室报告，门诊记录，放射学报告和病理报告，以精确匹配患者进行理想的临床试验。将我们的AI应用于基因组学数据将加速和降低风险研究，并更快地为患者带来改变生活的疗法。

Learn more about the Deep 6 AI genomics module here.

在这里了解有关Deep 6 AI genomics模块的更多信息。

About Deep 6 AI

大约深6 AI

Deep 6 AI is the leader in clinical trial acceleration software, enabling healthcare organizations and life sciences companies to optimize trial design, improve feasibility, and accelerate recruitment. Its AI-powered software mines structured and unstructured electronic medical record data to precisely match patients to clinical trials in real time.

Deep 6 AI是临床试验加速软件的领导者，使医疗机构和生命科学公司能够优化试验设计，提高可行性并加速招聘。其AI软件挖掘结构化和非结构化的电子病历数据，以实时精确地将患者与临床试验相匹配。

Visit deep6.ai to learn more..

访问deep6.ai了解更多信息。。

Media ContactLaurie Thackeray[email protected](919) 619-3105

媒体联系人Laurie Thackeray[电子邮件保护]（919）619-3105

SOURCE Deep 6 AI

源深6 AI